Market Risers: Antofagasta plc, Ashtead Group plc, AstraZeneca plc, Burberry Group plc

Antofagasta Plc
[shareaholic app="share_buttons" id_name="post_below_content"]

The share price for Antofagasta plc EPIC code: LON:ANTO has gained 3.91% or 32.6 points in today’s trading session so far. Buyers have stayed positive throughout the trading session. The periods high figure was 868.4 dropping as low as 848. The number of shares traded by this point in time totalled 1,321,328 with the daily average at 3,033,049. The 52 week high price for the shares is 1111.5 which is 277.1 points in difference to the previous days close of business and a 52 week low sitting at 713.2 which is a variance of 121.2 points. Antofagasta plc has a 20 day moving average of 821.67 and the 50 day moving average of 902.16. Market capitalisation is now £8,581.77m at the time of this report. The currency for this stock is Great British pence.Market cap is measured in GBP. This article was written with the last trade for Antofagasta plc being recorded at Tuesday, June 11, 2019 at 2:07:43 PM GMT with the stock price trading at 867 GBX.

Stock in Ashtead Group plc ticker code: LON:AHT has increased 1.26% or 24.5 points throughout the session so far. Buyers have so far held a positive outlook while the stock has been in play. The period high was 1978.5 meanwhile the session low reached 1955.5. The volume total for shares traded up to this point was 841,946 with the daily average traded share volume around 1,366,505. A 52 week share price high is 2461 which comes in at 511 points in difference on the previous days close and a 52 week low being 1572.5 is a variance of 377.5 points. Ashtead Group plc now has a 20 simple moving average of 1983.58 and the 50 day moving average of 2047.25. The market capitalisation currently stands at £9,214.74m at the time of this report. Share price is traded in GBX. Mcap is measured in GBP. This article was written with the last trade for Ashtead Group plc being recorded at Tuesday, June 11, 2019 at 2:08:09 PM GMT with the stock price trading at 1974.5 GBX.

Shares of AstraZeneca plc with company EPIC: LON:AZN has climbed 1.23% or 75 points during today’s session so far. Traders seem confident throughout the trading session. The period high has peaked at 6197 dropping as low as 6133. The total volume of shares traded by this point was 605,068 while the average shares exchanged is 2,116,799. The 52 week high price for the shares is 6540 some 436 points difference from the previous days close and putting the 52 week low at 5110 which is a difference of 994 points. AstraZeneca plc now has a 20 SMA of 5969.16 and now its 50 day moving average now of 5980. The current market capitalisation is £81,054.69m at the time of this report. Share price is traded in GBX. Mcap is measured in GBP. This article was written with the last trade for AstraZeneca plc being recorded at Tuesday, June 11, 2019 at 2:07:56 PM GMT with the stock price trading at 6179 GBX.

The trading price for Burberry Group plc company symbol: LON:BRBY has increased 1.88% or 33.5 points during today’s session so far. Market buyers have remained optimistic throughout the trading session. The high for the period has reached 1813.5 dipping to 1776.5. The total volume of shares exchanged through this period comes to 302,479 whilst the average number of shares exchanged is 1,558,500. The 52 week high is 2338 amounting to 558 points in difference on the previous days close and a 52 week low being 1618.5 a difference of some 161.5 points. Burberry Group plc has a 20 day moving average of 1813.58 and now the 50 day simple moving average now at 1912.47. The market capitalisation currently stands at £7,461.81m at the time of this report. Share price is traded in GBX. Mcap is measured in GBP. This article was written with the last trade for Burberry Group plc being recorded at Tuesday, June 11, 2019 at 2:07:24 PM GMT with the stock price trading at 1813.5 GBX.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:
    AstraZeneca Plc commits $3.5 billion to boost US research and manufacturing by 2026, creating jobs and expanding its innovation footprint.
    AstraZeneca and Amgen's Tezspire shows promise in reducing nasal polyp size and congestion, offering hope for chronic rhinosinusitis patients.

      Search

      Search